-
IntroducedJan 17, 2023
-
Passed House
-
Passed Senate
-
Became Law
United States House Bill
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Last Action See all actions
House • Jan 27, 2023: Referred to the Subcommittee on Health.
Latest Bill Text See all bill texts
Summary
Comments on HR 383
Tweets
Whip Lists
Sponsors



- Rep. Baird, James R.cosponsor
- Rep. Carter, Earl L. "Buddy"cosponsor
- Rep. Weber, Randy K., Sr.cosponsor
- Rep. Miller, Mary E.cosponsor
- Rep. Banks, Jimcosponsor
- Rep. Jackson, Ronnycosponsor
- Rep. Webster, Danielcosponsor
- Rep. Duncan, Jeffcosponsor
- Rep. Feenstra, Randycosponsor
- Rep. Smith, Christopher H.cosponsor
- Rep. Gosar, Paul A.cosponsor
- Rep. Sessions, Petecosponsor
- Rep. Flood, Mikecosponsor
- Rep. Grothman, Glenncosponsor
- Rep. Moolenaar, John R.cosponsor
- Rep. Boebert, Laurencosponsor
- Rep. Mast, Brian J.cosponsor
- Rep. Gonzales, Tonycosponsor
- Rep. Yakym, Rudycosponsor
- Rep. Bost, Mikecosponsor
- Rep. Guest, Michaelcosponsor
- Rep. Luna, Anna Paulinacosponsor
- Rep. Higgins, Claycosponsor
- Rep. Aderholt, Robert B.cosponsor
Votes
Actions
- Jan 27, 2023 | House
- Referred to the Subcommittee on Health.
- Jan 17, 2023 | House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.
Documents
